Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study.
Romano M, Gravina AG, Nardone G, Federico A, Dallio M, Martorano M, Mucherino C, Romiti A, Avallone L, Granata L, Priadko K, Compare D, Tuccillo C, Romito MR, Sgambato D, Miranda A, Romano L, Loguercio C, Bazzoli F, Zagari RM.
Romano M, et al. Among authors: compare d.
Helicobacter. 2020 Aug;25(4):e12694. doi: 10.1111/hel.12694. Epub 2020 Apr 20.
Helicobacter. 2020.
PMID: 32314519